NDC product
CAPSULE, DELAYED RELEASE PELLETS · Actavis Pharma, Inc.
NDC 0228-2890 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0228-2890 |
|---|---|
| Nonproprietary name | Duloxetine |
| Substances | DULOXETINE HYDROCHLORIDE |
| Dosage form | CAPSULE, DELAYED RELEASE PELLETS |
| Labeler | Actavis Pharma, Inc. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Feb 1, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: